Top Markets
#1 MON MON +2,759.42%
#2 $1 is all you need $1 is all you need +1,328.53%
#3 PYTHIA PYTHIA +44.53%
#4 eCash eCash +31.94%
#5 Siren Siren +24.14%
#6 SAFEcoin SAFEcoin +19.98%
#7 Janction Janction +18.96%
#8 PinGo PinGo +15.88%
#9 Velvet Velvet +15.84%
#10 Decred Decred +12.95%
Coin of the day
MON MON
設定
言語
日本
通貨
USD
テーマ
Sensorion SA Sensorion SA

Sensorion SA

ALSEN
株式のランク #13314
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
株価
$0.30780727
時価総額
$94.19M
変化（1日）
-0.19%
変化（1年）
-34.73%
国
FR
取引 Sensorion SA (ALSEN)

カテゴリー

Healthcare
Sensorion SA（ALSEN）のP/S比率
July 2026 時点のP/S比率 TTM: 31.10
Sensorion SA の最新の財務報告および株価によると、現在のP/S比率（TTM）は 31.10 です。2023 年末時点でのP/S比率は 10.07 でした。
Sensorion SA の P/S 比率の履歴（2011 ～ 2026）
各年末時点のP/S比率
年 P/S比率 変化
2026 (TTM) 31.10 14.55%
2024 27.15 169.61%
2023 10.07 68.16%
2022 5.99 -83.37%
2021 36.00 -7.10%
2020 38.75 504.07%
2019 6.41 24.60%
2018 5.15 -64.35%
2017 14.44 -99.23%
2016 1.87K 702.80%
2015 233.19 264.53%
2014 63.97 53.97%
2013 41.55 -35.02%
2012 63.94 -99.99%
2011 705.41K 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
4.26 -86.29%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.29 -66.92%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
4.31 -86.16%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.44 -79.28%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
16.96 -45.47%
NL